IMAGO PHARMACEUTICALS
Imago Pharmaceuticals is a virtual, privately held company developing JNK-directed novel therapies.
IMAGO PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical
Website Url:
http://www.imago-pharma.com
Status:
Active
Similar Organizations
Maxim Pharmaceuticals
Maxim Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative cancer therapeutics.
Current Employees Featured
Founder
Official Site Inspections
http://www.imago-pharma.com
- Host name: 172.65.185.109
- IP address: 172.65.185.109
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Imago Pharmaceuticals"
Imago Pharmaceuticals - Crunchbase Company Profile & Funding
Imago Pharmaceuticals is a virtual, privately held company developing JNK-directed novel therapies.See details»
Imago Pharmaceuticals Company Profile | Management and
Imago Pharmaceuticals Profile and History Imago Pharmaceuticals, Inc. is a pharmaceutical company developing novel therapies for neurodegenerative, inflammatory and autoimmune …See details»
Imago Pharmaceuticals - Overview, News & Similar companies
Who is Imago Pharmaceuticals. Imago Pharmaceuticals, Inc. is a pharmaceutical company developing novel therapies for neurodegenerative, inflammatory and autoimmune diseases, …See details»
Imago Pharmaceuticals, Inc. - LinkedIn
Imago Pharmaceuticals, Inc. | 17 followers on LinkedIn. Imago Pharmaceuticals - Improving Lives, Building a Future of Hope, a Focused Approach to SolutionsSee details»
Imago Pharmaceuticals: Contact Details and Business Profile
Imago Pharmaceuticals, Inc. is a pharmaceutical company developing novel therapies for neurodegenerative, inflammatory and autoimmune diseases, specifically focused on …See details»
Imago Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Imago Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 2 literature, Disease Domain:Nervous System Diseases, Endocrinology ...See details»
Imago Pharmaceuticals, Inc. Overview - SignalHire
Organization Website: imago-pharma.com : Imago Pharmaceutical... industries Pharma: Imago Pharmaceutical... Employees Size 1-10 employees: Founded: 2014: Imago Pharmaceuticals, …See details»
Imago Pharmaceuticals - Company Profile - Tracxn
Imago Pharmaceuticals - US-based, early-stage biopharma developing small molecule enzyme inhibitors for neurodegenerative, inflammatory, and autoimmune diseases. Founded by Karen …See details»
Imago Pharmaceuticals, Inc. overview - services, products, …
Learn about Imago Pharmaceuticals, Inc. - locations, products, equipment, revenue, and target industries. Read the latest news, find similar companies and employees, and moreSee details»
Imago Pharmaceuticals, Inc.:Company Profile & Technical Research ...
Imago Pharmaceuticals, Inc. is a company that provides Biophysics, Clinical trial, Biomedicine and more. Imago Pharmaceuticals, Inc. is headquartered in United States California. Imago …See details»
Imago Pharmaceuticals, Inc. Details - govtribe.com
Federal Vendor Profile for Imago Pharmaceuticals, Inc. GovTribe All Vendors Help . Imago Pharmaceuticals, Inc. UEI X2GUYBV2JCM7. Primary NAICS Category Not listed ... - …See details»
Imago (IMGO) Shares Surge 104% on Buyout Offer From Merck
Imago BioSciences (IMGO) to be acquired by pharma-giant Merck (MRK) for $1.35 billion. The transaction is likely to close by first-quarter 2023.See details»
Imago Pharmaceuticals is advancing our JNK (Jun N-terminal
Dec 17, 2016 Imago Pharmaceuticals is advancing our JNK (Jun N-terminal Kinase) Program into Pre-IND activities for CNS Diseases and FibrosisSee details»
Merck agrees to acquire Imago for $1.35bn - Pharmaceutical …
Nov 22, 2022 The Imago takeover will extend Merck’s growing haematology portfolio. Credit: Merck & Co., Inc., Rahway, NJ USA, and its affiliates. Merck (MSD outside North America) …See details»
Merck & Co. to acquire Imago BioSciences | C&EN Global Enterprise
Nov 28, 2022 It’s not Seagen but another company that Merck & Co. will acquire this year. The pharma giant will pay a total of $1.35 billion for Imago BioSciences. Merck’s acquisition of …See details»
What is Imago Pharmaceuticals? Company Culture, Mission, Values
Imago Pharmaceuticals. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. …See details»
Imago BioSciences Company Profile 2024: Valuation, Investors ...
Imago BioSciences General Information Description. Imago BioSciences Inc is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product …See details»
Merck & Co. to acquire Imago BioSciences - Chemical
Nov 23, 2022 The pharma giant will pay a total of $1.35 billion for Imago BioSciences. Merck’s acquisition of Imago strengthens the larger firm’s presence in hematology, says Hugh Y. …See details»
Merck Announces $1.35 Billion Acquisition of Imago BioSciences
Nov 28, 2022 Merck, known as MSD outside of the United States and Canada, announced its intention to acquire Imago BioSciences, a clinical-stage biopharmaceutical company focused …See details»
Merck to acquire Imago for $1.35 billion - European …
Nov 22, 2022 Merck has announced it will acquire biopharma Imago BioSciences, Inc for around $1.35 billion in total equity value, to facilitate development of Imago’s lead candidate …See details»